Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease-dependent airway epithelial responses to acute electronic cigarette aerosol exposure: a pilot single-cell analysis.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same author

Coolant Flavors Exacerbate Nicotine Effects in Craniofacial Cells.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Mitochondrial dysfunction due to myeloid TFAM loss limits senolytic efficacy in allergic airway inflammation.

American journal of respiratory cell and molecular biology·2026
Same author

Upholding Scientific Rigor in the Age of Generative AI: What FASEB's New Policy Means for The FASEB Journal and FASEB BioAdvances.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

E-Cigarette Use Trajectories and Respiratory Symptoms in Adolescents and Young Adults: Sustained Use Linked to Greater Symptom Frequency.

Journal of studies on alcohol and drugs·2026
Same author

Cardiopulmonary and Immune Effects of Environmental Particulate Exposures.

Physiology (Bethesda, Md.)·2026
Same journal

Left ventricular excessive trabeculation: pathophysiology, diagnostic challenges, and prognostic significance.

Heart failure reviews·2026
Same journal

Tachycardia-induced cardiomyopathy: evolution of the concept and contemporary insights.

Heart failure reviews·2026
Same journal

Mavacamten in adolescent obstructive hypertrophic cardiomyopathy: SCOUTing a way forward.

Heart failure reviews·2026
Same journal

Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Heart failure reviews·2026
Same journal

Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.

Heart failure reviews·2026
Same journal

Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.

Heart failure reviews·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Metabolic dysfunction in diabetic cardiomyopathy.

Michael Isfort1, Sarah C W Stevens, Stephen Schaffer

  • 1The Ohio State University College of Medicine, Columbus, OH, USA.

Heart Failure Reviews
|February 28, 2013
PubMed
Summary
This summary is machine-generated.

Diabetic cardiomyopathy (DCM) is a heart condition linked to diabetes mellitus (DM). Understanding metabolic shifts and therapeutic options is key to managing this growing global health issue.

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Related Experiment Videos

Last Updated: May 13, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Biochemistry

Background:

  • Diabetic cardiomyopathy (DCM) is a heart failure syndrome in diabetic patients, independent of other vascular issues.
  • DCM is characterized by left ventricular hypertrophy and diastolic dysfunction, often without hypertension or coronary artery disease.
  • The rising incidence of diabetes mellitus (DM) globally parallels an epidemic rise in new DCM cases.

Purpose of the Study:

  • To review the limiting steps in pathological pathways contributing to DCM.
  • To describe regulatory factors involved in these pathways.
  • To outline current and potential therapeutic strategies for DCM.

Main Methods:

  • This review synthesizes existing literature on DCM pathophysiology and treatment.
  • It focuses on the metabolic interplay between glucose and fatty acid utilization in the heart.
  • Key regulatory mechanisms of glycolytic enzymes and their role in DCM are examined.

Main Results:

  • Hyperglycemia and hyperlipidemia, common in DM, potentiate DCM severity.
  • Inhibition of key glycolytic enzymes can divert substrates into pathological pathways, promoting DCM.
  • Metabolic competition between glucose and fatty acids in the heart is a critical regulatory point.

Conclusions:

  • DCM development involves specific limiting steps in pathological metabolic pathways.
  • Understanding these pathways and their regulation is crucial for therapeutic development.
  • Targeting metabolic dysregulation offers potential treatment avenues for DCM.